Jacc: Cardiooncology

JACC: CardioOncology is a specialized journal that belongs to the esteemed Journal of the American College of Cardiology (JACC) family. Its purpose is to enhance cardiovascular care for cancer patients by publishing high-quality, innovative scientific research and sharing evidence-based knowledge. The journal aims to revolutionize the field of cardio-oncology and actively involve and educate professionals in both cardiovascular and oncology fields. It covers a wide range of topics including pre-clinical, translational, and clinical research, as well as best practices in cardio-oncology. Key areas of focus include understanding disease mechanisms, utilizing in vitro and in vivo models, exploring novel and traditional therapeutics (across Phase I-IV trials), studying epidemiology, employing precision medicine, and investigating primary and secondary prevention. Amyloidosis, cardiovascular risk factors, heart failure, and vascular disease are some examples of the disease states that are of particular interest to the journal. However, it welcomes research on other relevant conditions as well.

《JACC：CardioOncology》是美国心脏病学会杂志（JACC）家族的一份专业期刊，旨在通过发表高质量、创新的科学研究和分享循证知识来加强癌症患者的心血管护理。该期刊致力于彻底改变心脏肿瘤学领域，积极参与和教育心血管和肿瘤学领域的专业人员。它涵盖了临床前、转化和临床研究等广泛主题，重点关注领域包括疾病机制、体内外模型、疗法探索、流行病学研究、精准医学和预防。淀粉样变性、心血管危险因素、心力衰竭和血管疾病等是该期刊特别感兴趣的疾病状态，同时也欢迎对其他相关条件进行研究。